London-listed medical group AMS draws private equity interest

Business

A medical technology company which produces tissue-healing surgical products has become the latest London-listed business to draw interest from buyout firms.

Sky News has learnt that Inflexion, the private equity group, has been studying a takeover of Advanced Medical Solutions Group (AMS Group), which has a market capitalisation of over £500m.

On Tuesday evening, it was unclear whether any active talks were taking place between the two parties, although sources close to both played down any suggestion of live deal negotiations.

Other private equity firms are also said to have been circling AMS Group in recent weeks.

AMS Group, which manufactures surgical brands including LiquiBand and Resorba, is scheduled to publish its half-year results on Wednesday.

It is likely to face questions from analysts and investors about whether it has engaged in any recent discussions about a take-private.

Inflexion’s interest has emerged amid a flurry of bids for London-listed companies, the latest of which involved TI Fluid Systems, a maker of automotive components.

More from Business

On Tuesday, shares in AMS Group closed over 4% higher at 241.5p.

The stock has risen by nearly a third over the last 12 months.

Inflexion and AMS Group both declined to comment.

Articles You May Like

Kanye West accused of sexual assault on set of music video in new lawsuit
Human Cell Atlas Mapping 37 Trillion Human Cells for Disease Insights
FTX co-founder Gary Wang avoids prison time for role in crypto fraud
UK to scrap warships, helicopters and drone fleet despite growing threats abroad
Anaesthetist jailed for 190 years for tampering with IV bags used in surgeries